AMERICAN JOURNAL OF EMERGENCY MEDICINE, vol.36, no.3, pp.435-441, 2018 (SCI-Expanded)
Aim: This study aims to evaluate the serum S100B levels to predict neuronal damage and poor clinical outcomes associated with the use of synthetic cannabinoids.